Clinical research has become a fundamental step in the development of a dietary supplement. Nutraceutical companies are investing more in clinical research than ever before to support health and marketing claims and gain a competitive advantage in a saturated marketplace.
Joshua Baisley, B.Sc., is the Associate Director of Clinical Trials at Nutrasource. Connect with Josh on LinkedIn.
Clinical research in Canada has been declining year over year since 2010. Fluctuations are sometimes seen due to the changing strength of the Canadian versus American dollar as the costs are typically quite similar between countries. Another factor in the recent downturn has been partially credited to Sponsors and contract research organizations (CROs) placing studies in foreign countries or being misinformed that data must be produced in the country they are marketing in. These factors have led to CROs and sites to move to, or open operations in, other countries to adapt.
Ingredient Marketplace is sure to be a hit this year as the popular health products trade show heads south to Orlando, Florida.
This year the conference has put together a list of hot topics based on actual requests from registered attendees. Categories include energy, cognitive health, cardiovascular health and non-GMO ingredients. Attendees can search for exhibitors within each category, allowing them to easily find companies they are interested in doing business with.
As we prepare for Ingredient Marketplace, we take a look back at some of our customers’ success stories within these “hot topics” categories. Read on to learn how we helped them achieve their business goals, whether it was to bring products to new markets or support novel health claims.
By: Joshua Baisley, B.Sc., Associate Director of Clinical Trials, and Rachel Rebry, M.Sc., Associate Director of Nutrition and Nutraceutical Research
The verdict is in on one of the two high-profile dietary supplement industry cases before the courts this year. The decision from the U.S. Court of Appeals for the D.C. Circuit upheld the Federal Trade Commission's (FTC) charges that POM Wonderful and POMx ads were deceptive. The ads claimed that the product could treat, prevent or reduce the risk of heart disease and prostate cancer, but lacked clinical evidence to substantiate such claims.
The decision led to questions around how much clinical evidence is required to support a health claim. How is a company promoting the benefits of natural health products supposed to navigate the regulatory landscape when even the guidances are not clear?
The dietary supplement industry continues, year after year, to gain consumer confidence. In 2013, the Council for Responsible Nutrition (CRN) published the results of a consumer survey reporting that 83% of American adults are confident in the “safety, quality and effectiveness of dietary supplements”. But with every two steps forward supplements make on building consumer confidence, it seems they fall one step backward.
Mismanaged or poorly controlled data is a clinical investigator’s nightmare. As the integrity of a clinical trial is dependent on how data is collected, stored and secured, having an effective data management system in place is critical.
In our latest free guide, available for download below, our data management team provides important insight into the fundamentals of data management in a clinical research setting, from study start-up to database lock and statistical analysis, and offers tips on how you can ensure your clinical data is properly managed.
Last week at Engredea, co-located with Natural Products Expo West, our President & CEO, William Rowe, gave a lecture on how product-specific data can be used to successfully market foods and health products while achieving return on investment (ROI).
As a contract research organization, we have helped hundreds of health product companies navigate the regulatory landscape and successfully bring their products to market.
Choosing a contract research organization (CRO) can be a daunting task. The primary concern of each of our clients, whether they be from the pharmaceutical, natural health product, or functional food industries, is getting their product to market on time and on budget. But what do each of our clients look for when choosing a CRO?
Nutrasource has had its fair share of clients facing research and development challenges. In today's post the NDI team focuses on the five most common R&D challenges when it comes to the health product development. The team also offers advice on how to survive (and thrive) when faced with these challenges.